Citigroup Inc. Sells 5,112 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Citigroup Inc. decreased its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 21.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 18,486 shares of the medical instruments supplier’s stock after selling 5,112 shares during the quarter. Citigroup Inc.’s holdings in Mettler-Toledo International were worth $27,723,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in MTD. PineStone Asset Management Inc. raised its stake in shares of Mettler-Toledo International by 127.4% during the 2nd quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock valued at $362,855,000 after purchasing an additional 145,453 shares during the period. TD Asset Management Inc grew its holdings in Mettler-Toledo International by 1.9% during the 2nd quarter. TD Asset Management Inc now owns 157,247 shares of the medical instruments supplier’s stock valued at $219,767,000 after buying an additional 2,866 shares in the last quarter. Massachusetts Financial Services Co. MA increased its position in shares of Mettler-Toledo International by 32.5% during the second quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier’s stock valued at $199,777,000 after buying an additional 35,048 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in shares of Mettler-Toledo International by 88.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 122,655 shares of the medical instruments supplier’s stock worth $163,290,000 after buying an additional 57,509 shares in the last quarter. Finally, International Assets Investment Management LLC boosted its position in shares of Mettler-Toledo International by 149,870.0% in the third quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier’s stock valued at $134,946,000 after acquiring an additional 89,922 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Analysts Set New Price Targets

Several analysts have issued reports on MTD shares. Evercore ISI increased their target price on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. Wells Fargo & Company decreased their price target on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. Robert W. Baird dropped their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research note on Monday, November 11th. Stifel Nicolaus decreased their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Finally, JPMorgan Chase & Co. lifted their price target on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research report on Monday, August 5th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Mettler-Toledo International currently has a consensus rating of “Hold” and an average price target of $1,338.75.

Insider Activity

In other news, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the sale, the director now owns 240 shares of the company’s stock, valued at approximately $314,820. The trade was a 24.05 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.94% of the company’s stock.

Mettler-Toledo International Trading Up 0.6 %

Shares of NYSE MTD opened at $1,224.99 on Tuesday. The stock has a market cap of $25.85 billion, a price-to-earnings ratio of 33.03, a P/E/G ratio of 4.02 and a beta of 1.16. The stock’s 50-day moving average is $1,358.47 and its 200 day moving average is $1,399.52. Mettler-Toledo International Inc. has a 1-year low of $1,059.08 and a 1-year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The firm had revenue of $954.54 million during the quarter, compared to analyst estimates of $941.93 million. On average, analysts forecast that Mettler-Toledo International Inc. will post 40.39 EPS for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.